Daniel Wrapp News Today

Jason McLellan’s groundbreaking research is changing the way vaccines are developed—including those for another formidable pathogen, RSV.

$100,000 prize to be awarded at Dartmouth on May 13

Posted: May 02, 2021 6:00 AM NT | Last Updated: May 2 comments Jason McLellan in his lab at the University of Texas at Austin in February 2020. Many of the COVID vaccines that have been developed used Dr. McLellan’s research. (College of Natural Sciences, University of Texas at Austin) This column is an instalment in our series , in which cultural historian Ainsley Hawthorn examines the issues of COVID-19 through the lens of the past. Past pandemics can bring our experiences with COVID-19 ...

Share This The FINANCIAL -- In a major boost to efforts to combat COVID-19 globally, a vaccine that recently entered human trials in Vietnam and Thailand, and is slated for a clinical study in Brazil, holds promise for affordable vaccine manufacturing in countries currently dependent on imported vaccines. The vaccine is the result of a partnership between The University of Texas at Austin, the Icahn School of Medicine at Mount Sinai in New York and global partners interested in advancing the...

Tiny antibodies naturally generated by llamas can be effective against COVID-19 As the fight against COVID-19 continues, scientists have turned to an unlikely source for a potentially effective treatment: tiny antibodies naturally generated by llamas. While the world has welcomed the news of multiple vaccines against COVID-19, the search for effective treatments for those who contract the virus is ongoing. Now scientists are looking to what might seem to be an unlikely source: the South America...

(57 votes) Remnant Editors Note: One of the signatories of this important document is a survivor of brutal medical experiments conducted in the Nazi concentration camp at Ravensbrück. We published her story back in 2019 in The Remnant Newspaper and online here at RemnantNewspaper.com. It goes without saying that we here at The Remnant are not only willing, but anxious to publish the following Press Release and Open Letter. - MJM PRESS RELEASE An international group of nearly 100 women doctors,...

 E-Mail As the fight against COVID-19 continues, scientists have turned to an unlikely source for a potentially effective treatment: tiny antibodies naturally generated by llamas. While the world has welcomed the news of multiple vaccines against COVID-19, the search for effective treatments for those who contract the virus is ongoing. Now scientists are looking to what might seem to be an unlikely source: the South American llama. Researchers are using the ultrabright X-rays of the Advance...

Researchers are using the ultra-bright X-rays of the Advanced Photon Source, an accelerator at Argonne National Laboratory, to help turn naturally generated llama antibodies into potentially effective therapies against COVID-19.

Jason McLellan in his lab on January 18, 2021. Credit: Matt Wright-Steel On January 6, 2020, Jason McLellan and his wife, Jinelle, were in Park City, Utah, for their family’s first-ever snowboarding vacation. It was a chance for the couple and their two young kids to relax after the holidays and before the spring semester kicked off at UT, when McLellan would begin his second year as an associate professor in molecular biosciences.    McLellan’s new snowboarding boots were pinching him...

Luck, foresight and science: How an unheralded team developed a COVID-19 vaccine in record time Credit for Modernas COVID-19 vaccine belongs in part to discoveries dating back 15 years. The team behind it was inspired by two infant deaths. David Heath and Gus Garcia-Roberts, USA TODAY Published 9:25 pm UTC Jan. 31, 2021 Credit for Modernas COVID-19 vaccine belongs in part to discoveries dating back 15 years. The team behind it was inspired by two infant deaths. David Heath and Gus Garcia-Rober...